Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

April 01, 2015 07:00 ET | Source: Sigma-Tau Pharmaceuticals

Sigma-Tau Pharmaceuticals, Inc. Receives Orphan Drug Designation for STP-206 for Prevention of Necrotizing Enterocolitis

GAITHERSBURG, Md., April 1, 2015 (GLOBE NEWSWIRE) -- Sigma-Tau Pharmaceuticals, Inc., announced today that the U.S. Food and Drug Administration (FDA) has granted an orphan drug designation for the...
March 30, 2015 08:57 ET | Source: Sigma-Tau Pharmaceuticals

Sigma-Tau Pharmaceuticals, Inc. Receives Orphan Drug Designation for EZN-2279 for Treatment of Adenosine deaminase--Deficient Severe Combined Immunodeficiency Disease

GAITHERSBURG, Md., March 30, 2015 (GLOBE NEWSWIRE) -- Sigma-Tau Pharmaceuticals Inc. announced today that the U.S. Food and Drug Administration (FDA) has granted an orphan drug designation for the...
August 11, 2014 07:30 ET | Source: Sigma-Tau Pharmaceuticals

Sigma-Tau Pharmaceuticals, Inc. Signs Exclusive Agreement With Crosscare Limited for U.S. Marketing and Distribution License of Colief(R) Infant Drops for the Treatment of Colic-Associated Crying

GAITHERSBURG, Md. and OAKBROOK TERRACE, Ill., Aug. 11, 2014 (GLOBE NEWSWIRE) -- Sigma-Tau Pharmaceuticals, Inc. (Sigma-Tau) today announced that the Company has signed an exclusive U.S. license...
July 31, 2014 07:30 ET | Source: Sigma-Tau Pharmaceuticals

Walgreens Named Exclusive Specialty Pharmacy Provider for Sigma-Tau Pharmaceuticals, Inc.'s Prescription Drugs: Adagen(R), Cystaran(R) and Matulane(R)

GAITHERSBURG, Md. and DEERFIELD, Ill., July 31, 2014 (GLOBE NEWSWIRE) -- Sigma-Tau Pharmaceuticals, Inc. (Sigma-Tau), and Walgreens (NYSE:WAG) (Nasdaq:WAG) today announced that, effective July 31,...
February 04, 2014 07:00 ET | Source: Sigma-Tau Pharmaceuticals

Sigma-Tau Pharmaceuticals, Inc. Announces First Patient Dosed in Phase I/II Clinical Trial of STP206 for Prevention of Necrotizing Enterocolitis in Very Low Birth Weight Premature Infants

GAITHERSBURG, Md., Feb. 4, 2014 (GLOBE NEWSWIRE) -- Sigma-Tau Pharmaceuticals, Inc. (Sigma-Tau) today announced that the first patient has been dosed as part of the Company's Phase I/II multi-center,...
May 01, 2013 08:37 ET | Source: Sigma-Tau Pharmaceuticals

Sigma-Tau Pharmaceuticals Launches CYSTARAN(TM) for the Treatment of Corneal Cystine Crystal Accumulation in Patients With Cystinosis

GAITHERSBURG, Md., May 1, 2013 (GLOBE NEWSWIRE) -- Sigma-Tau Pharmaceuticals, Inc. (Sigma-Tau), a part of the Sigma-Tau Group Rare Disease Franchise, announced today the availability of...
April 29, 2013 08:43 ET | Source: Sigma-Tau Pharmaceuticals

Dave Lemus Promoted to Chief Executive Officer of Sigma-Tau Pharmaceuticals, Inc.

GAITHERSBURG, Md., April 29, 2013 (GLOBE NEWSWIRE) -- The Board of Directors of Sigma-Tau Pharmaceuticals, Inc. today announced that Dave Lemus has been promoted to the newly created position of Chief...
October 29, 2012 09:05 ET | Source: Sigma-Tau Pharmaceuticals

Sigma-Tau Pharmaceuticals, Inc. Announces Appointment of New Vice President of Commercial Operations

GAITHERSBURG, Md., Oct. 29, 2012 (GLOBE NEWSWIRE) -- Sigma-Tau Pharmaceuticals, Inc. today announced the appointment of Jeff Hackman as its new Vice President of Commercial Operations. Mr. Hackman has...
October 16, 2012 08:43 ET | Source: Sigma-Tau Pharmaceuticals

Sigma-Tau Pharmaceuticals, Inc. Announces the U.S. Launch of VSL#3(R) JUNIOR

GAITHERSBURG, Md., Oct. 16, 2012 (GLOBE NEWSWIRE) -- Sigma-Tau Pharmaceuticals, Inc. announced today the U.S. launch of VSL#3® JUNIOR, a once-a-day, high-potency probiotic medical food for the...
October 09, 2012 08:43 ET | Source: Sigma-Tau Pharmaceuticals

Sigma-Tau Pharmaceuticals Inc. Offers New Co-Pay Assistance Program for Adagen(R) Patients

GAITHERSBURG, Md., Oct. 9, 2012 (GLOBE NEWSWIRE) -- Continuing its dedication to those patients impacted by rare diseases, today Sigma-Tau Pharmaceuticals, Inc. announced that it will expand its...